Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-516634-35-00Phase 4Authorised
Phase 4, randomised, double-blind trial in status epilepticus (SE) comparing Intravenous valproic acid with Intravenous levetiracetam (2 arms). Planned start Aug 2020; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-516634-35-00.